Half of H.I.V. Patients Are Women. Most Research Subjects Are Men.

Trials of vaccines and treatments have not included enough female participants. Now that scientists are exploring possible cures, the need to enroll women is greater than ever.
The New York Times
By APOORVA MANDAVILLI from NYT Health https://nyti.ms/2EAVymk
May 27, 2019 at 02:00PM